Defining a new threshold for PSA outcomes in untreated prostate cancer.

被引：0
|
作者：
Beekman, KW [1 ]
Wilton, A [1 ]
Heller, G [1 ]
Bianco, FJ [1 ]
Lilja, H [1 ]
Slovin, S [1 ]
Scardino, PT [1 ]
Scher, HI [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页码：403S / 403S
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of PSA in the outcomes of patients with high risk localized prostate cancer.
    Khosla, Atulya Aman
    Prabhakar, Pushan
    Pon Avudaiappan, Arjun
    Jatwani, Karan
    Ahluwalia, Manmeet Singh
    Manoharan, Murugesan
    Garje, Rohan
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 347 - 347
  • [2] Optimized use of PSA for diagnosis of prostate cancer.
    Stenman, Ulf-Hakan
    TUMOR BIOLOGY, 2006, 27
  • [3] Effect of obesity on PSA density (PSAD): A new clinical predictor of prostate cancer.
    Garzotto, M.
    Mongoue-Tchokote, S.
    Shannon, J.
    Peters, L.
    Sokoloff, M. H.
    Beer, T. M.
    Mori, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 245S - 245S
  • [4] Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.
    Couvillon, Anna
    Turkbey, Baris
    Lindenberg, Maria Liza
    Choyke, Peter L.
    Kaushal, Aradhana
    Citrin, Deborah E.
    Krauze, Andra V.
    McNally, Deborah
    McKinney, Yolanda
    Martinez, Mirna
    Han, Hui
    Karzai, Fatima
    Parnes, Howard L.
    Pinto, Peter A.
    Gulley, James L.
    Dahut, William L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Association of NaF PET/CT findings with PSA and alkaline phosphatase in untreated castration-sensitive prostate cancer.
    Couvillon, Anna
    Turkbey, Baris
    Lindenberg, Maria Liza
    Choyke, Peter L.
    Martinez, Mirna
    McKinney, Yolanda
    Kaushal, Aradhana
    Citrin, Deborah E.
    Krauze, Andra
    McNally, Deborah
    Giordano, Luz
    Chun, Guinevere
    Royce, Cheryl
    Han, Hui
    Karzai, Fatima
    Parnes, Howard L.
    Pinto, Peter A.
    Gulley, James L.
    Dahut, William L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [6] PSA related screening of prostate cancer. Panic or improvement?
    Fornara, P
    Jurczok, A
    AKTUELLE UROLOGIE, 2004, 35 (01) : 43 - 48
  • [7] Development of a home PSA test for the screening of prostate cancer.
    Remaley, AT
    Chan, Y
    Samantha, B
    Hu, X
    Julie, P
    Ray, R
    CLINICAL CHEMISTRY, 2001, 47 (06) : A138 - A138
  • [8] Complexed PSA enhances specificity in the detection of prostate cancer.
    Cheli, CD
    Miller, MC
    Veltri, R
    CLINICAL CHEMISTRY, 2001, 47 (06) : A128 - A128
  • [9] Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time
    Ng, Michael K.
    Van As, Nicholas
    Thomas, Karen
    Woode-Amissah, Ruth
    Horwich, Alan
    Huddart, Robert
    Khoo, Vincent
    Thompson, Alan
    Dearnaley, David
    Parker, Chris
    BJU INTERNATIONAL, 2009, 103 (07) : 872 - 876
  • [10] Defining a molecular subclass of treatment resistant prostate cancer.
    Beltran, Himisha
    Prandi, Davide
    Mosquera, Juan Miguel
    Giannopoulou, Eugenia
    Puca, Loredana
    Marotz, Clarisse
    Nanus, David M.
    Tagawa, Scott T.
    Elemento, Olivier
    Van Allen, Eliezer Mendel
    Sboner, Andrea
    Garraway, Levi A.
    Rubin, Mark A.
    Demichelis, Francesca
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345